Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)

SWOG has endorsed this study through the Cancer Trials Support Unit (CTSU) of the National Cancer Institute.

Please contact CTSU directly by phone (888/823-5923) or on the CTSU website (http://ctsu.org) for more information and registration procedures.